Skip to main content
Navigate Up
Sign In
 

Neuromuscular

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: (view all)

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator PRA
17-1816 A phase 2, double-blind, randomized, placebo-controlled, multiple dose study of ck-2127107 in two ascending dose cohorts of patients with spinal muscular atrophy (sma) Dixon, Stacy, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
17-0734 A phase 2, multi-center, double-blind, randomized, dose-ranging, placebo-controlled study to evaluate the efficacy, safety, and tolerability of ck-2127107 in patients with amyotrophic lateral sclerosis (als) Quan, Dianna, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
08-0623 Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey Of Patients With Documented Transthyretin (TTR) Mutations Or Wild-Type TTR Amyloidosis Quan, Dianna, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
04-0567 Use of 3,4-Diaminopyridine, and Investigational new drug, in Lambert-Eaton Syndrome Quan, Dianna, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
17-1396 Prospective, double-blind, randomized, placebo-controlled phase iii study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (proderm study) Quan, Dianna, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
17-1132 Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study Wicklund, Matthew, MD Nicola Haakonsen
303-724-4644
Eligibility and Information